{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:10:40Z","timestamp":1790392240823,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T00:00:00Z","timestamp":1453075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81172458"],"award-info":[{"award-number":["81172458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302243"],"award-info":[{"award-number":["81302243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171978"],"award-info":[{"award-number":["81171978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81472484"],"award-info":[{"award-number":["81472484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81172460"],"award-info":[{"award-number":["81172460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81301785"],"award-info":[{"award-number":["81301785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007128","name":"the Natural Science Foundation of Shaanxi province","doi-asserted-by":"crossref","award":["2014JM4157"],"award-info":[{"award-number":["2014JM4157"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s13277-015-4699-x","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T02:02:38Z","timestamp":1453082558000},"page":"9423-9431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-chun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,18]]},"reference":[{"issue":"1","key":"4699_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CACancer J Clin. 2014;64(1):9\u201329.","journal-title":"CACancer J Clin"},{"issue":"2","key":"4699_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4699_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.canlet.2011.12.036","volume":"342","author":"BS Gloss","year":"2014","unstructured":"Gloss BS, Samimi G. Epigenetic biomarkers in epithelial ovarian cancer. Cancer Lett. 2014;342(2):257\u201363.","journal-title":"Cancer Lett"},{"key":"4699_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","volume":"13","author":"M Felder","year":"2014","unstructured":"Felder M, Kapur A, Gonzalez-Bosquet J, et al. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol Cancer. 2014;13:129.","journal-title":"Mol Cancer"},{"issue":"1","key":"4699_CR5","doi-asserted-by":"crossref","first-page":"e0005","DOI":"10.5041\/RMMJ.10180","volume":"6","author":"J Menczer","year":"2015","unstructured":"Menczer J, Ben-Shem E, Golan A, et al. The significance of normal pretreatment levels of CA125 (<35 U\/mL) in epithelial ovarian carcinoma. Rambam Maimonides Med J. 2015;6(1):e0005.","journal-title":"Rambam Maimonides Med J"},{"issue":"3","key":"4699_CR6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4331\/wjbc.v5.i3.286","volume":"5","author":"JG Cohen","year":"2014","unstructured":"Cohen JG, White M, Cruz A, et al. In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol Chem. 2014;5(3):286\u2013300.","journal-title":"World J Biol Chem"},{"issue":"6","key":"4699_CR7","first-page":"335","volume":"7","author":"AK Karam","year":"2010","unstructured":"Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nature reviews. Clin Oncol. 2010;7(6):335\u20139.","journal-title":"Clin Oncol"},{"issue":"5","key":"4699_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","volume":"15","author":"MJ Duffy","year":"2005","unstructured":"Duffy MJ, Bonfrer JM, Kulpa J, et al. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer. 2005;15(5):679\u201391.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"4699_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.RES.0000207919.83894.9d","volume":"98","author":"T Ago","year":"2006","unstructured":"Ago T, Sadoshima J. GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res. 2006;98(3):294\u20137.","journal-title":"Circ Res"},{"issue":"6","key":"4699_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.5483\/BMBRep.2006.39.6.649","volume":"39","author":"TE Eling","year":"2006","unstructured":"Eling TE, Baek SJ, Shim M, et al. NSAID activated gene (NAG-1), a modulator of tumorigenesis. J Biochem Mol Biol. 2006;39(6):649\u201355.","journal-title":"J Biochem Mol Biol"},{"issue":"5","key":"4699_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08977194.2011.607137","volume":"29","author":"SN Breit","year":"2011","unstructured":"Breit SN, Johnen H, Cook AD, et al. The TGF-beta superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors. 2011;29(5):187\u201395.","journal-title":"Growth Factors"},{"issue":"7","key":"4699_CR12","first-page":"2642","volume":"9","author":"DA Brown","year":"2003","unstructured":"Brown DA, Ward RL, Buckhaults P, et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res. 2003;9(7):2642\u201350.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4699_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3892\/etm.2013.1361","volume":"7","author":"G Yang","year":"2014","unstructured":"Yang G, Tan Q, Xie Y, et al. Variations in NAG-1 expression of human gastric carcinoma and normal gastric tissues. Exp Ther Med. 2014;7(1):241\u20135.","journal-title":"Exp Ther Med"},{"issue":"2","key":"4699_CR14","doi-asserted-by":"crossref","first-page":"e55171","DOI":"10.1371\/journal.pone.0055171","volume":"8","author":"S Kaur","year":"2013","unstructured":"Kaur S, Chakraborty S, Baine MJ, et al. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. PLoS One. 2013;8(2):e55171.","journal-title":"PLoS One"},{"key":"4699_CR15","doi-asserted-by":"crossref","unstructured":"Mehta RS, Song M, Bezawada N, et al. A prospective study of macrophage inhibitory cytokine-1 (MIC-1\/GDF15) and risk of colorectal cancer. J Natl Cancer Inst. 2014;106(4):dju016.","DOI":"10.1093\/jnci\/dju016"},{"issue":"1","key":"4699_CR16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/plac.2002.0881","volume":"24","author":"AB Marjono","year":"2003","unstructured":"Marjono AB, Brown DA, Horton KE, et al. Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta. 2003;24(1):100\u20136.","journal-title":"Placenta"},{"issue":"7","key":"4699_CR17","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","volume":"10","author":"J Koopmann","year":"2004","unstructured":"Koopmann J, Buckhaults P, Brown DA, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res. 2004;10(7):2386\u201392.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4699_CR18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 2014;133(3):401\u20134.","journal-title":"Gynecol Oncol"},{"key":"4699_CR19","unstructured":"Kaku T, Watanabe S, Ohishi Y. [Pathology of ovarian cancer]. Nihon rinsho. Jap J Clin Med. 2012;70(l 4):512\u2013516."},{"key":"4699_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-60761-806-5_12","volume":"664","author":"R Simon","year":"2010","unstructured":"Simon R, Mirlacher M, Sauter G. Immunohistochemical analysis of tissue microarrays. Methods Mol Biol. 2010;664:113\u201326.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"4699_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast Jr RC, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4699_CR22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","volume":"104","author":"EV Hogdall","year":"2007","unstructured":"Hogdall EV, Christensen L, Kjaer SK, et al. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish \"MALOVA\" Ovarian Cancer Study. Gynecol Oncol. 2007;104(3):508\u201315.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4699_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajog.2008.04.009","volume":"199","author":"V Nossov","year":"2008","unstructured":"Nossov V, Amneus M, Su F, et al. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol. 2008;199(3):215\u201323.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4699_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/GRF.0b013e3182460c0d","volume":"55","author":"JR Nagell Van Jr","year":"2012","unstructured":"Van Nagell Jr JR, Pavlik EJ. Ovarian cancer screening. Clin Obstet Gynecol. 2012;55(1):43\u201351.","journal-title":"Clin Obstet Gynecol"},{"issue":"9","key":"4699_CR25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1940-6207.CAPR-11-0378","volume":"4","author":"O Dorigo","year":"2011","unstructured":"Dorigo O, Berek JS. Personalizing CA125 levels for ovarian cancer screening. Cancer Prev Res. 2011;4(9):1356\u20139.","journal-title":"Cancer Prev Res"},{"issue":"1","key":"4699_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2009.09.019","volume":"116","author":"WD Kang","year":"2010","unstructured":"Kang WD, Choi HS, Kim SM. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. Gynecol Oncol. 2010;116(1):57\u201360.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4699_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","volume":"85","author":"X Wang","year":"2013","unstructured":"Wang X, Baek SJ, Eling TE. The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer. Biochem Pharmacol. 2013;85(5):597\u2013606.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"4699_CR28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","volume":"98","author":"J Xu","year":"2006","unstructured":"Xu J, Kimball TR, Lorenz JN, et al. GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res. 2006;98(3):342\u201350.","journal-title":"Circ Res"},{"issue":"19","key":"4699_CR29","first-page":"6996","volume":"61","author":"P Buckhaults","year":"2001","unstructured":"Buckhaults P, Rago C, Croix BS, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 2001;61(19):6996\u20137001.","journal-title":"Cancer Res"},{"issue":"9","key":"4699_CR30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00432-008-0362-x","volume":"134","author":"JY Park","year":"2008","unstructured":"Park JY, Park KH, Bang S, et al. Expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas. J Cancer Res Clin Oncol. 2008;134(9):1029\u201335.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"4699_CR31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/fon.13.263","volume":"10","author":"M Blanco-Calvo","year":"2014","unstructured":"Blanco-Calvo M, Tarrio N, Reboredo M, et al. Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer. Future Oncol. 2014;10(7):1187\u2013202.","journal-title":"Future Oncol"},{"issue":"7","key":"4699_CR32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.oraloncology.2012.01.020","volume":"48","author":"E Schiegnitz","year":"2012","unstructured":"Schiegnitz E, Kammerer PW, Koch FP, et al. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma. Oral Oncol. 2012;48(7):608\u201314.","journal-title":"Oral Oncol"},{"issue":"6","key":"4699_CR33","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/annonc\/mdu120","volume":"25","author":"CZ Yang","year":"2014","unstructured":"Yang CZ, Ma J, Zhu DW, et al. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Ann Oncol. 2014;25(6):1215\u201322.","journal-title":"Ann Oncol"},{"issue":"10","key":"4699_CR34","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/bjc.2011.112","volume":"104","author":"U Wallin","year":"2011","unstructured":"Wallin U, Glimelius B, Jirstrom K, et al. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br J Cancer. 2011;104(10):1619\u201327.","journal-title":"Br J Cancer"},{"issue":"11","key":"4699_CR35","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/ijc.24639","volume":"125","author":"S Shnaper","year":"2009","unstructured":"Shnaper S, Desbaillets I, Brown DA, et al. Elevated levels of MIC-1\/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. Int J Cancer. 2009;125(11):2624\u201330.","journal-title":"Int J Cancer"},{"issue":"3","key":"4699_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","volume":"118","author":"AC Staff","year":"2010","unstructured":"Staff AC, Bock AJ, Becker C, et al. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer. Gynecol Oncol. 2010;118(3):237\u201343.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"4699_CR37","first-page":"1448","volume":"20","author":"AJ Bock","year":"2010","unstructured":"Bock AJ, Stavnes HT, Kempf T, et al. Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions. Int J Gynecol Cancer. 2010;20(9):1448\u201355.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"4699_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cam4.354","volume":"4","author":"JC Meier","year":"2015","unstructured":"Meier JC, Haendler B, Seidel H, et al. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis. Cancer Med. 2015;4(2):253\u201367.","journal-title":"Cancer Med"}],"updated-by":[{"DOI":"10.1007\/s13277-016-5008-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000}}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4699-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4699-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T15:36:52Z","timestamp":1567525012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4699-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,18]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4699-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13277-016-5008-z","asserted-by":"object"}]},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,18]]}}}